tumor-induced osteomalacia
MeSH: C537751ORPHA: 3525401 Treatment Available
Overview
medical condition
Available Treatments (1)
| Drug | Form | Status | Countries | Lead Time |
|---|---|---|---|---|
| Calcipotriol | Cream, Ointment, Solution | Approved | 4 | 5d |
Clinical Presentation
Signs and symptoms associated with tumor-induced osteomalacia, sourced from HPO and Orphanet clinical annotations.
Renal phosphate wastingMuscle weaknessHypophosphatemiaPathologic fractureHyperphosphaturiaElevated circulating alkaline phosphatase concentrationNephrocalcinosisBone painIncreased susceptibility to fracturesOsteomalaciaProximal muscle weaknessBowing of the long bonesNeoplasm of the skeletal systemLow serum calcitriolAbnormal circulating fibroblast growth factor 23 concentrationPectus carinatumNephrolithiasisGait disturbanceGrowth delayAbnormal foot morphologyAbnormality of the tarsal bonesRespiratory insufficiencyOsteosarcomaKyphosisAbnormal femur morphologyHypocalcemiaTibial bowingAbnormal fibula morphologyHypophosphatemic ricketsFibrous dysplasia of the bonesGiant cell tumor of boneNeoplasm of head and neckAbnormal pelvis bone morphologyAbnormal vertebral morphologyCarcinoma
Classification & Codes
MeSH Code
C537751Orphanet Code
ORPHA:352540tumor-induced osteomalacia
| MeSH | C537751 |
| Orphanet | ORPHA:352540 |
| Treatments | 1 drug(s) |
| Symptoms on record | 35 signs |
| Status | published |
Treatment Summary
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO